1731 REDUCTION OF PROSTATE CANCER INCIDENCE BY NAFTOPIDIL, AN α1 ADRENOCEPTOR ANTAGONIST AND INHIBITOR OF TRANSFORMING GROWTH FACTOR-β SIGNALING

D. Yamada,H. Nishimatsu,Shintaro Kumano,Yoshikazu Hirano,Motofumi Suzuki,T. Fujimura,H. Fukuhara,Y. Enomoto,H. Kume,Y. Homma

Published 2013 in The Journal of Urology

ABSTRACT

No abstract is available for this paper.

PUBLICATION RECORD

Publication year
2013
Venue
The Journal of Urology
Publication date
2013-04-01
Fields of study
Medicine
Identifiers
DOI 10.1016/J.JURO.2013.02.2901
External record
Open on Semantic Scholar
Source metadata
Semantic Scholar

CITATION MAP

EXTRACTION MAP

CLAIMS

No claims are published for this paper.

CONCEPTS

No concepts are published for this paper.

REFERENCES

No references are available for this paper.

CITED BY

Kurosawa Hospital DEPENDING ON THE TYPE OF ALPHA-AR BLOCKAGE USED IN COMBINATION WITH DUTASTERIDE , THERE IS A DIFFERENCE IN SERUM PSA DECREASE RATE AND PROSTATE
2017cites this paper